NasdaqCM - Delayed Quote • USD
Equillium, Inc. (EQ)
At close: April 23 at 4:00 PM EDT
After hours: April 23 at 5:40 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
36,084.0000
36,084.0000
15,759.0000
--
--
Operating Expense
50,606.0000
50,606.0000
54,786.0000
37,786.0000
29,548.0000
Operating Income
-14,522.0000
-14,522.0000
-39,027.0000
-37,786.0000
-29,548.0000
Net Non Operating Interest Income Expense
1,843.0000
1,843.0000
-633.0000
-1,016.0000
-623.0000
Other Income Expense
-76.0000
-76.0000
-22,768.0000
-250.0000
358.0000
Pretax Income
-12,755.0000
-12,755.0000
-62,428.0000
-39,052.0000
-29,813.0000
Tax Provision
580.0000
580.0000
--
--
--
Net Income Common Stockholders
-13,335.0000
-13,335.0000
-62,428.0000
-39,052.0000
-29,813.0000
Diluted NI Available to Com Stockholders
-13,335.0000
-13,335.0000
-62,428.0000
-39,052.0000
-29,813.0000
Basic EPS
-0.38
--
-1.85
-1.36
-1.46
Diluted EPS
-0.38
--
-1.85
-1.36
-1.46
Basic Average Shares
34,726.3840
--
33,727.9450
28,806.3100
20,355.5340
Diluted Average Shares
34,726.3840
--
33,727.9450
28,806.3100
20,355.5340
Total Operating Income as Reported
-14,522.0000
-14,522.0000
-62,076.0000
-37,786.0000
-29,548.0000
Total Expenses
50,606.0000
50,606.0000
54,786.0000
37,786.0000
29,548.0000
Net Income from Continuing & Discontinued Operation
-13,335.0000
-13,335.0000
-62,428.0000
-39,052.0000
-29,813.0000
Normalized Income
-13,335.0000
-13,335.0000
-39,379.0000
-39,052.0000
-29,813.0000
Interest Income
2,334.0000
2,334.0000
420.0000
57.0000
476.0000
Interest Expense
491.0000
491.0000
1,053.0000
1,073.0000
1,099.0000
Net Interest Income
1,843.0000
1,843.0000
-633.0000
-1,016.0000
-623.0000
EBIT
-12,264.0000
-12,264.0000
-61,375.0000
-37,979.0000
-28,714.0000
EBITDA
-12,138.0000
-12,138.0000
-61,257.0000
-37,907.0000
-28,669.0000
Reconciled Depreciation
126.0000
126.0000
118.0000
72.0000
45.0000
Net Income from Continuing Operation Net Minority Interest
-13,335.0000
-13,335.0000
-62,428.0000
-39,052.0000
-29,813.0000
Total Unusual Items Excluding Goodwill
--
--
-23,049.0000
--
--
Total Unusual Items
--
--
-23,049.0000
--
--
Normalized EBITDA
-12,138.0000
-12,138.0000
-38,208.0000
-37,907.0000
-28,669.0000
Tax Rate for Calcs
0.0002
0.0002
--
--
--
12/31/2020 - 10/12/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CNTB Connect Biopharma Holdings Limited
1.3900
+2.96%
TRVI Trevi Therapeutics, Inc.
2.8500
-3.06%
NRBO NeuroBo Pharmaceuticals, Inc.
3.0200
-3.21%
ASLN ASLAN Pharmaceuticals Limited
0.4690
+3.08%
ANRO Alto Neuroscience, Inc.
13.88
+1.76%
RZLT Rezolute, Inc.
2.8600
-19.21%
MIST Milestone Pharmaceuticals Inc.
1.7000
+4.29%
ELEV Elevation Oncology, Inc.
4.3200
+6.67%
RVPH Reviva Pharmaceuticals Holdings, Inc.
3.0600
-0.97%
IMRN Immuron Limited
2.4600
-5.38%